Canon U.S.A. (Lake Success, NY) recently introduced the CX-1, said to be the world’s first fully hybrid mydriatic/nonmydriatic digital retinal camera. The image-processing capabilities of Canon’s EOS camera technology have been adapted exclusively for medical use in the CX-1, providing up to 15.1-Mpixel resolution.
Offering automatic, single-touch switching between mydriatic and nonmydriatic modes, the camera can also take FAF (fundus autofluorescence) photographs, which could eliminate the need to refer patients to an ophthalmologist. Until now, FAF photography has only been possible when in mydriatic camera mode.
The ability to use the nonmydriatic mode for detecting autoflourescence of the retina not only saves time and resources, it also can make the procedure more comfortable for the patient. The CX-1 can deliver clear and detailed diagnostic images for virtually immediate review. The single onboard digital camera easily handles five different photography modes, including nonmydriatic FAF, color, red-free, cobalt, and fluorescein angiography photography.
The camera also includes intuitive, user-friendly retinal-imaging-control software, which gives users access to tools for comprehensive study management, image-capture controls, and easy viewing. The PC-based software provides quick input and access to all information and images required to assist in patient diagnosis, and data can be easily saved to various external media.
The camera has not yet been cleared by the FDA, and is not available for sale or lease in the United States. For more information about other Canon ophthalmic devices and solutions, visit http://www.usa.canon.com/eye-care.
Christina D’Airo
Advertisement
Learn more about Canon U.S.A.
